Stephanie Dyson

Vice President, Head of Government Affairs & Policy, Biogen

Fast Facts


  • MA, political management and public policy, George Washington University
  • BS, Nyack College, 2007
  • AASN, Nursing, University of the District of Columbia

Selected work history

  • Senior Director, Head of U.S. Policy, Genentech, 2009-2017
  • Vice President, DaVita, 2005-2009
  • Various Roles, Centers for Medicare and Medicaid Services, culminating in a Senior Level “Box Top” position
  • Manager, Ernst & Young, 1995-1999

Stephanie Dyson didn’t start out as a policy professional. She began her career as a registered nurse after earning her degree from the University of the District of Columbia. 

A move to Ernst & Young quickly exposed Dyson to the world of health care policy, and it eventually took her to the Centers for Medicare and Medicaid Services for a six-year stint. There, she served in numerous roles, working on the development and implementation of Medicare Part D in the George W. Bush administration. She ultimately moved up to deputy office director of the Office of External Affairs.

But the private sector soon beckoned. Dyson first landed at dialysis company DaVita before moving to biotech firm Genentech, where she focused on ensuring that oncology patients receive personalized health care. After stops at Achaogen and United Healthcare, she moved to Biogen, a company focused on biotechnology for neurological afflictions. She rejects a “one-size-fit- all” approach to health care, drawing on her background as a nurse to promote patient-centric care in public policy. She’s an avid supporter of voting and diversity initiatives within Biogen, and she’s participated in the Women of Color in Pharma Conference.

This report is brought to you by our Vignette research team. Vignette, by National Journal, is a new database service, which now includes 10,000 in-depth profiles on policymakers and influencers at the federal, state, and local levels. Sign up to access profiles at